Key Segmentation
By Type
- Nucleotides
- Capping Agents
- Plasmid DNA
- Enzymes
- Others
By Application
- Vaccine Production
- Therapeutics Production
- Others
By End User
- Biopharmaceutical & Pharmaceutical Companies
- CDMOs
- Others
By Raw Material Grade
- GMP-Grade
- Research-Use-Only (RUO)
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- ASEAN Countries
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Available Customization
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g. Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
The mRNA Synthesis Raw Materials Market is expected to grow at a CAGR of 7.70% from 2026 to 2035.
The mRNA Synthesis Raw Materials Market was valued at USD 1.85 Billion in 2025.
The growing mRNA vaccine and therapeutic pipeline combined with expansion of GMP-compliant manufacturing is the major growth factor.
The Nucleotides segment held approximately 38.50% share in 2025.
North America held the largest share of the mRNA Synthesis Raw Materials Market in 2025.